BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali. An energy-restricted high-protein diet supplemented with β-cryptoxanthin alleviated oxidative stress and inflammation in nonalcoholic fatty liver disease: a randomized controlled trialNutrition Research 2020; 73: 15 doi: 10.1016/j.nutres.2019.08.009
2
Nahum Méndez-Sánchez, Eira Cerda-Reyes, Fátima Higuera-de-la-Tijera, Ana K. Salas-García, Samantha Cabrera-Palma, Guillermo Cabrera-Álvarez, Carlos Cortez-Hernández, Luis A Pérez-Arredondo, Emma Purón-González, Edgar Coronado-Alejandro, Arturo Panduro, Heriberto Rodríguez-Hernández, Vania C. Cruz-Ramón, Alejandro Valencia-Rodríguez, Xingshun Qi, Nashla Hamdan-Pérez, Nancy E. Aguilar-Olivos, Beatriz Barranco-Fragoso, Oscar Ramírez-Pérez, Alfonso Vera-Barajas. Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitisF1000Research 2020; 9: 56 doi: 10.12688/f1000research.21918.1
3
Seonghae Yoon, Heechan Lee, Sang-Chun Ji, Seo Hyun Yoon, Joo-Youn Cho, Jae-Yong Chung. Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver FunctionClinical Pharmacology in Drug Development 2020;  doi: 10.1002/cpdd.790
4
Muhammad Sohaib Asghar, Maira Hassan, Uzma Rasheed, Syed Jawad Haider Kazmi, Noman A Khan, Faran Khalid, Ayesha Anum, Saira Anwar. Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver DiseaseCureus 2020;  doi: 10.7759/cureus.11146
5
Rohit Loomba, Robert Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen Harrison, Stuart C. Gordon. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataAlimentary Pharmacology & Therapeutics 2020; 51(11): 1149 doi: 10.1111/apt.15679
6
Razk Abdalgwad, Mohammed F. Rafey, Siobhan Foy, Micheál Newell, Colin Davenport, Derek T. O'Keeffe, Francis M. Finucane. Long-Term Changes in Weight in Patients With Severe and Complicated Obesity After Completion of a Milk-Based Meal Replacement ProgrammeFrontiers in Nutrition 2020; 7 doi: 10.3389/fnut.2020.551068
7
Thaddeus J. Maguire, Aditya Shreenivas, William S. Rilling. Image-Guided Interventions in Oncology2020; : 81 doi: 10.1007/978-3-030-48767-6_6
8
Shan Dang, Jian Zhou, Zongyan Wang, Kunning Wang, Shejiao Dai, Shuixiang He. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinomaBiomedicine & Pharmacotherapy 2018; 106: 966 doi: 10.1016/j.biopha.2018.06.042
9
Yi-Shu Chen, Dan Chen, Chao Shen, Ming Chen, Chao-Hui Jin, Cheng-Fu Xu, Chao-Hui Yu, You-Ming Li. A novel model for predicting fatty liver disease by means of an artificial neural networkGastroenterology Report 2020;  doi: 10.1093/gastro/goaa035
10
Tamoore Arshad, Pegah Golabi, James Paik, Alita Mishra, Zobair M. Younossi. Prevalence of Nonalcoholic Fatty Liver Disease in the Female PopulationHepatology Communications 2019; 3(1): 74 doi: 10.1002/hep4.1285
11
Risa M. Wolf, Kiyoko Oshima, Joseph K. Canner, Kimberley E. Steele. Impact of a preoperative low-calorie diet on liver histology in patients with fatty liver disease undergoing bariatric surgerySurgery for Obesity and Related Diseases 2019; 15(10): 1766 doi: 10.1016/j.soard.2019.08.013
12
Mohamed I. Elsaid, You Li, Carolyn Catalano, Carlos D. Minacapelli, Kapil Gupta, Vinod K. Rustgi. Healthcare Utilization and Cost Burden of Porphyria in Commercially Insured Adults in the United StatesPharmacoEconomics - Open 2020;  doi: 10.1007/s41669-020-00229-4
13
Hande Erman, Engin Beydogan, Seher Irem Cetin, Banu Boyuk. Endocan: A Biomarker for Hepatosteatosis in Patients with Metabolic SyndromeMediators of Inflammation 2020; 2020: 1 doi: 10.1155/2020/3534042
14
Sydney Pomenti, Cassandra Gandle, Hamzah Abu Sbeih, Meaghan Phipps, Alexandra Livanos, Averill Guo, Jonathan Yeh, Heather Burney, Hao Liu, Lara Dakhoul, Carla Kettler, Samer Gawrieh, Andrew deLemos, Andrew Scanga, Naga Chalasani, Ethan Miller, Julia Wattacheril. Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States CohortHepatology Communications 2020; 4(11): 1708 doi: 10.1002/hep4.1575
15
Allyce Caines, Ranya Selim, Reena Salgia. The Changing Global Epidemiology of Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 535 doi: 10.1016/j.cld.2020.06.001
16
Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti, Sanatan Shreay, Maria Letizia Petroni, Giulio Marchesini. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in ItalyNutrition, Metabolism and Cardiovascular Diseases 2020; 30(6): 1014 doi: 10.1016/j.numecd.2020.02.016
17
Idrees Suliman, Noha Abdelgelil, Farah Kassamali, Tarek I. Hassanein. The Effects of Hepatic Steatosis on the Natural History of HBV InfectionClinics in Liver Disease 2019; 23(3): 433 doi: 10.1016/j.cld.2019.05.001
18
Verena C Obmann, Christina Marx, Annalisa Berzigotti, Nando Mertineit, Joris Hrycyk, Christoph Gräni, Lukas Ebner, Michael Ith, Johannes T Heverhagen, Andreas Christe, Adrian T Huber. Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosisEuropean Journal of Radiology 2019; 118: 66 doi: 10.1016/j.ejrad.2019.07.001
19
Rebecca K. Vincent, David M. Williams, Marc Evans. A look to the future in non‐alcoholic fatty liver disease: Are glucagon‐like peptide‐1 analogues or sodium‐glucose co‐transporter‐2 inhibitors the answer?Diabetes, Obesity and Metabolism 2020; 22(12): 2227 doi: 10.1111/dom.14196
20
Sarayu A. Pai, Renuka P. Munshi, Falguni H. Panchal, Ila-Shruti Gaur, Snehal N. Mestry, Malvika S. Gursahani, Archana R. Juvekar. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stressBiomedicine & Pharmacotherapy 2019; 111: 686 doi: 10.1016/j.biopha.2018.12.139
21
Lauren A. Newman, Michael J. Sorich, Andrew Rowland. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver DiseaseJournal of Clinical Medicine 2020; 9(7): 2032 doi: 10.3390/jcm9072032
22
Yingfei Xi, Hongshan Li. Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver diseaseBiomedicine & Pharmacotherapy 2020; 121: 109609 doi: 10.1016/j.biopha.2019.109609
23
Yang Zou, Ling Zhong, Chong Hu, Guotai Sheng. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal studyLipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01419-z
24
Gaurav Gupta, Ridhima Wadhwa, Parijat Pandey, Sachin Kumar Singh, Monica Gulati, Saurabh Sajita, Meenu Mehta, Avinash Kumar Singh, Harish Dureja, Trudi Collet, Kavita Pabreja, Dinesh Kumar Chellappan, Kamal Dua. Pathophysiology of Obesity-Induced Health Complications2020; : 81 doi: 10.1007/978-3-030-35358-2_5
25
Hongwei Yi, Deyi Xu, Xudong Wu, Fang Xu, Lin Lin, Huiping Zhou. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic InjuryviaModulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress PathwaysAntioxidants & Redox Signaling 2019; 30(17): 1949 doi: 10.1089/ars.2018.7521
26
Xiangmeng Chen, Teng Ma, Rowena Yip, Ponni V. Perumalswami, Andrea D. Branch, Sara Lewis, Michael Crane, David F. Yankelevitz, Claudia I. Henschke. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screeningClinical Imaging 2020; 60(2): 237 doi: 10.1016/j.clinimag.2019.12.009
27
Stuart C. Gordon, Jeremy Fraysse, Suying Li, A. Burak Ozbay, Robert J. Wong. Disease Severity Is Associated With Higher Healthcare Utilization in Nonalcoholic Steatohepatitis Medicare PatientsThe American Journal of Gastroenterology 2020; 115(4): 562 doi: 10.14309/ajg.0000000000000484
28
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013670
29
Rajesh Krithika, Ramtej Jayaram Verma. Hypolipidemic and Hypoglycemic Effects of Hydroalcoholic Extract of Solanum nigrum Linn. in CCl4-induced Hepatotoxicity in MiceToxicology and Environmental Health Sciences 2018; 10(5): 268 doi: 10.1007/s13530-018-0375-z
30
Marc Evans, Angharad R. Morgan, Dipesh Patel, Ketan Dhatariya, Sharlene Greenwood, Philip Newland-Jones, Debbie Hicks, Zaheer Yousef, Jim Moore, Bethany Kelly, Sarah Davies, Umesh Dashora. Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsDiabetes Therapy 2020;  doi: 10.1007/s13300-020-00963-2
31
Enxiang Zhang, Shutao Yin, Shuang Zhao, Chong Zhao, Mingzhu Yan, Lihong Fan, Hongbo Hu. Protective effects of glycycoumarin on liver diseasesPhytotherapy Research 2020; 34(6): 1191 doi: 10.1002/ptr.6598
32
Salvatore Corrao, Giuseppe Natoli, Christiano Argano. Nonalcoholic fatty liver disease is associated with intrahepatic cholangiocarcinoma and not with extrahepatic formEuropean Journal of Gastroenterology & Hepatology 2020;  doi: 10.1097/MEG.0000000000001684
33
Jitka Starekova, Scott B. Reeder. Liver fat quantification: where do we stand?Abdominal Radiology 2020; 45(11): 3386 doi: 10.1007/s00261-020-02783-1
34
Alexander L. Ticho, Pooja Malhotra, Pradeep K. Dudeja, Ravinder K. Gill, Waddah A. Alrefai. Comprehensive Physiology2019; : 21 doi: 10.1002/cphy.c190007
35
Yuwei Wu, Jinyu Wang, Xiaodong Zheng, Yongyan Chen, Mei Huang, Qiang Huang, Weihua Xiao, Haiming Wei, Zhigang Tian, Rui Sun, Cheng Sun. Establishment and Preclinical Therapy of Patient-derived Hepatocellular Carcinoma Xenograft ModelImmunology Letters 2020; 223: 33 doi: 10.1016/j.imlet.2020.04.009
36
Dajana Lichtenstein, Claudia Luckert, Jimmy Alarcan, Georges de Sousa, Michail Gioutlakis, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad Peijnenburg, Roger Rahmani, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana J. Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Albert Braeuning, Alfonso Lampen. An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitroFood and Chemical Toxicology 2020; 139: 111283 doi: 10.1016/j.fct.2020.111283
37
Elham Karimi-Sales, Sajad Jeddi, Mohammad Reza Alipour. trans-Chalcone inhibits transforming growth factor-β1 and connective tissue growth factor-dependent collagen expression in the heart of high-fat diet-fed ratsArchives of Physiology and Biochemistry 2020; : 1 doi: 10.1080/13813455.2020.1764045
38
Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, Franco Folli. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)Pharmacological Research 2018; 137: 219 doi: 10.1016/j.phrs.2018.09.025
39
Hao Chiang, Hsu-Feng Lu, Jui-Chieh Chen, Yu-Hsin Chen, Hsi-Tai Sun, Hsiu-Chen Huang, Hsiao-Hsuan Tien, Cheng Huang. Adlay Seed (Coix lacryma-jobi L.) Extracts Exhibit a Prophylactic Effect on Diet-Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in MiceEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/9519625
40
Annah P. Baykal, Elizabeth J. Parks, Robert Shamburek, Majid M. Syed-Abdul, Shaji Chacko, Elaine Cochran, Megan Startzell, Ahmed M. Gharib, Ronald Ouwerkerk, Khaled Z. Abd-Elmoniem, Peter J. Walter, Mary Walter, Ranganath Muniyappa, Stephanie T. Chung, Rebecca J. Brown. Leptin decreases de novo lipogenesis in patients with lipodystrophyJCI Insight 2020; 5(14) doi: 10.1172/jci.insight.137180
41
Jing Xie, Yong Shao, Jin Liu, Meilan Cui, Xiuxiao Xiao, Jingbo Gong, Binghua Xue, Qunwei Zhang, Xianwen Hu, Haifeng Duan. K27Q/K29Q mutations in sphingosine kinase 1 attenuate high-fat diet induced obesity and altered glucose homeostasis in miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-77096-w
42
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials Cureus 2020;  doi: 10.7759/cureus.9018
43
Minjuan Ma, Rui Duan, Hong Zhong, Tingming Liang, Li Guo. The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLDJournal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/3954890
44
Jarren R. Oates, Melanie C. McKell, Maria E. Moreno-Fernandez, Michelle S. M. A. Damen, George S. Deepe, Joseph E. Qualls, Senad Divanovic. Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac AttackFrontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.02893
45
Somaya Albhaisi, Arun J. Sanyal. Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to DatePharmaceutical Medicine 2019; 33(6): 451 doi: 10.1007/s40290-019-00305-z
46
Somaya Albhaisi, Arun Sanyal. Recent advances in understanding and managing non-alcoholic fatty liver diseaseF1000Research 2018; 7: 720 doi: 10.12688/f1000research.14421.1
47
Reem Al-Qarni, Muhammad Iqbal, Maram Al-Otaibi, Faisal Al-Saif, Assim A. Alfadda, Hisham Alkhalidi, Fahad Bamehriz, Mazen Hassanain. Validating candidate biomarkers for different stages of non-alcoholic fatty liver diseaseMedicine 2020; 99(36): e21463 doi: 10.1097/MD.0000000000021463
48
Associated Liver Disease in Alcoholic Chronic PancreatitisAcademia Journal of Surgery 2020; 3(1): 172 doi: 10.47008/ajs/2020.3.1.37
49
Si-Qin Long, Xiu-Feng Yu, Yu-Li Ge, Lu-Xiang Liu. Ginkgolide B ameliorates high-fat diet-induced hepatic steatosis and inflammation in miceWorld Chinese Journal of Digestology 2020; 28(13): 519 doi: 10.11569/wcjd.v28.i13.519
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
50
Joseph M. Salamoun, Christopher J. Garcia, Stefan R. Hargett, Jacob H. Murray, Sing-Young Chen, Martina Beretta, Stephanie J. Alexopoulos, Divya P. Shah, Ellen M. Olzomer, Simon P. Tucker, Kyle L. Hoehn, Webster L. Santos. 6-Amino[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Nonalcoholic SteatohepatitisJournal of Medicinal Chemistry 2020; 63(11): 6203 doi: 10.1021/acs.jmedchem.0c00542
51
Vincenzo Cuccurullo, Giuseppe Danilo Di Stasio, Giuseppe Mazzarella, Giuseppe Lucio Cascini. Microvascular Invasion in HCC: The Molecular Imaging PerspectiveContrast Media & Molecular Imaging 2018; 2018: 1 doi: 10.1155/2018/9487938
52
Lívia Pimentel de Sant'Ana, Dalila Juliana S. Ribeiro, Aline Maria Araújo Martins, Fábio Neves dos Santos, Rafael Corrêa, Raquel das Neves Almeida, Marcos Nogueira Eberlin, Corinne F. Maurice, Kelly Grace Magalhães. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese MiceFrontiers in Immunology 2020; 10 doi: 10.3389/fimmu.2019.02926
53
Joise Teixeira, Cláudio Augusto Marroni, Paula Rosales Zubiaurre, Ana Henz, Lais Faina, Lilian Kethelyn Pinheiro, Claudio Cora Mottin, Sabrina Alves Fernandes. Phase angle and non-alcoholic fatty liver disease before and after bariatric surgeryWorld Journal of Hepatology 2020; 12(11): 1004-1019 doi: 10.4254/wjh.v12.i11.1004
54
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka. Current status, problems, and perspectives of non-alcoholic fatty liver disease researchWorld Journal of Gastroenterology 2019; 25(2): 163-177 doi: 10.3748/wjg.v25.i2.163
55
Rongjia Qi, Rong Jiang, Hanxianzhi Xiao, Ziling Wang, Siyuan He, Lu Wang, Yaping Wang. Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factorLife Sciences 2020; 254: 117776 doi: 10.1016/j.lfs.2020.117776
56
Claudia Luckert, Albert Braeuning, Georges de Sousa, Sigrid Durinck, Efrosini S. Katsanou, Parthena Konstantinidou, Kyriaki Machera, Emanuela S. Milani, Ad A. C. M. Peijnenburg, Roger Rahmani, Andreja Rajkovic, Deborah Rijkers, Anastasia Spyropoulou, Marianna Stamou, Geert Stoopen, Shana Sturla, Bernd Wollscheid, Nathalie Zucchini-Pascal, Alfonso Lampen. Adverse Outcome Pathway-Driven Analysis of Liver Steatosis in Vitro: A Case Study with CyproconazoleChemical Research in Toxicology 2018; 31(8): 784 doi: 10.1021/acs.chemrestox.8b00112
57
Ioan Sporea, Ruxandra Mare, Alina Popescu, Silviu Nistorescu, Victor Baldea, Roxana Sirli, Adina Braha, Alexandra Sima, Romulus Timar, Raluca Lupusoru. Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life ExperienceJournal of Clinical Medicine 2020; 9(4): 1032 doi: 10.3390/jcm9041032
58
Manca Povsic, Louisa Oliver, Neha Raju Jiandani, Richard Perry, Juliana Bottomley. A structured literature review of interventions used in the management of nonalcoholic steatohepatitis ( NASH ) Pharmacology Research & Perspectives 2019; 7(3): e00485 doi: 10.1002/prp2.485
59
Xian-ju Huang, Cai-jing He, Shuai Liang, Jing Wang, Jun Li, Guang-zhong Yang, Zhang Zhao. Veratrilla baillonii Franch Could Alleviate Lipid Accumulation in LO2 Cells by Regulating Oxidative, Inflammatory, and Lipid Metabolic Signaling PathwaysFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.575772
60
Joseph Pierre Aboumsallem, Ilayaraja Muthuramu, Mudit Mishra, Bart De Geest. Cholesterol-Lowering Gene Therapy Prevents Heart Failure with Preserved Ejection Fraction in Obese Type 2 Diabetic MiceInternational Journal of Molecular Sciences 2019; 20(9): 2222 doi: 10.3390/ijms20092222
61
Andrea Gonzalez, Camila Huerta-Salgado, Josué Orozco-Aguilar, Francisco Aguirre, Franco Tacchi, Felipe Simon, Claudio Cabello-Verrugio, Ana Cipak Gasparovic. Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/1617805
62
Jiang-Hua Zhou, Jing-Jing Cai, Zhi-Gang She, Hong-Liang Li. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practiceWorld Journal of Gastroenterology 2019; 25(11): 1307-1326 doi: 10.3748/wjg.v25.i11.1307
63
Naga Swetha Samji, Rajanshu Verma, Krishna Chaitanya Keri, Ashwani K. Singal, Aijaz Ahmed, Mary Rinella, David Bernstein, Manal F. Abdelmalek, Sanjaya K. Satapathy. Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical ChallengesDigestive Diseases and Sciences 2019; 64(12): 3413 doi: 10.1007/s10620-019-05716-1
64
Jamie O'Hara, Alan Finnegan, Harpal Dhillon, Leonardo Ruiz-Casas, Gabriel Pedra, Bethany Franks, George Morgan, Vanessa Hebditch, Bengt Jönsson, Mzwandile Mabhala, Tatjana Reic, Ingo Van Thiel, Vlad Ratziu, Manuel Romero-Gomez, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee. Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN studyJHEP Reports 2020; 2(5): 100142 doi: 10.1016/j.jhepr.2020.100142
65
Seungtae On, Hyun Young Kim, Hyo Seon Kim, Jeongwoo Park, Keon Wook Kang. Involvement of G-Protein-Coupled Receptor 40 in the Inhibitory Effects of Docosahexaenoic Acid on SREBP1-Mediated Lipogenic Enzyme Expression in Primary HepatocytesInternational Journal of Molecular Sciences 2019; 20(11): 2625 doi: 10.3390/ijms20112625
66
Ciniso Sylvester Shabangu, Jee-Fu Huang, Hui-Hua Hsiao, Ming-Lung Yu, Wan-Long Chuang, Shu-Chi Wang. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver DiseasesInternational Journal of Molecular Sciences 2020; 21(10): 3732 doi: 10.3390/ijms21103732
67
Eréndira Villanueva-Ortega, Lucia A. Méndez-García, Guadalupe N. Garibay-Nieto, Estibalitz Laresgoiti-Servitje, Patricia Medina-Bravo, Alfonso Olivos-García, Martín H. Muñoz-Ortega, Javier Ventura-Juárez, Galileo Escobedo. Growth hormone ameliorates high glucose-induced steatosis on in vitro cultured human HepG2 hepatocytes by inhibiting de novo lipogenesis via ChREBP and FAS suppressionGrowth Hormone & IGF Research 2020; : 101332 doi: 10.1016/j.ghir.2020.101332
68
Peter M. Graffy, Veit Sandfort, Ronald M. Summers, Perry J. Pickhardt. Automated Liver Fat Quantification at Nonenhanced Abdominal CT for Population-based Steatosis AssessmentRadiology 2019; 293(2): 334 doi: 10.1148/radiol.2019190512
69
Banrida Wahlang, Savitri Appana, K. Cameron Falkner, Craig J. McClain, Guy Brock, Matthew C. Cave. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003–2004Environmental Science and Pollution Research 2020; 27(6): 6476 doi: 10.1007/s11356-019-07066-x
70
Alexandra Zaborowski, Helen M. Heneghan, Barbara Fiore, Anthony Stafford, Tom Gallagher, Justin Geoghegan, Donal Maguire, Emir Hoti. Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo ProtocolTransplantation 2020; 104(10): 2097 doi: 10.1097/TP.0000000000003114
71
Christian S. Alvarez, Barry I. Graubard, Jake E. Thistle, Jessica L. Petrick, Katherine A. McGlynn. Attributable Fractions of Nonalcoholic Fatty Liver Disease for Mortality in the United States: Results From the Third National Health and Nutrition Examination Survey With 27 Years of Follow‐upHepatology 2020; 72(2): 430 doi: 10.1002/hep.31040
72
Florence Wong, K. Rajender Reddy, Jacqueline G. O’Leary, Guadalupe Garcia‐Tsao, Patrick S. Kamath, Jasmohan S. Bajaj. ReplyLiver Transplantation 2019; 25(10): 1586 doi: 10.1002/lt.25612
73
Hideki Fujii, Haruna Doi, Tetsuhisa Ko, Taito Fukuma, Toru Kadono, Kohei Asaeda, Reo Kobayashi, Takahiro Nakano, Toshifumi Doi, Yoshikazu Nakatsugawa, Shinya Yamada, Takeshi Nishimura, Naoya Tomatsuri, Hideki Sato, Yusuke Okuyama, Hiroyuki Kimura, Etsuko Kishimoto, Nami Nakabe, Takatomo Shima. Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort studyBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01369-x
74
Manca Povsic, On Yee Wong, Richard Perry, Juliana Bottomley. A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH)Advances in Therapy 2019; 36(7): 1574 doi: 10.1007/s12325-019-00960-3
75
Scott A. Reisman, Deborah A. Ferguson, Chun‐Yue I. Lee, Joel W. Proksch. Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitisJournal of Biochemical and Molecular Toxicology 2020; 34(9) doi: 10.1002/jbt.22526
76
Felipe David Mendonça Chaim, Lívia Bitencourt Pascoal, Fábio Henrique Mendonça Chaim, Bruna Biazon Palma, Tiago Andrade Damázio, Larissa Bastos Eloy da Costa, Rita Carvalho, Everton Cazzo, Martinho Antônio Gestic, Murillo Pimentel Utrini, Marciane Milanski, Elinton Adami Chaim, Raquel Franco Leal. Histological grading evaluation of non-alcoholic fatty liver disease after bariatric surgery: a retrospective and longitudinal observational cohort studyScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65556-2
77
Lauren S. Strathearn, Afanasii I. Stepanov, Joan Font-Burgada. Inflammation in Primary and Metastatic Liver Tumorigenesis–Under the Influence of Alcohol and High-Fat DietsNutrients 2020; 12(4): 933 doi: 10.3390/nu12040933
78
Jana Hudcova, Syed Talha Qasmi, Robin Ruthazer, Ahsan Waqas, Syed Basit Haider, Roman Schumann. Early Allograft Dysfunction Following Liver Transplant: Impact of Obesity, Diabetes, and Red Blood Cell TransfusionTransplantation Proceedings 2020;  doi: 10.1016/j.transproceed.2020.02.168
79
Magdy El-Gohary, Mike Moore, Paul Roderick, Emily Watkins, Joanne Dash, Tina Reinson, Colin Newell, Miranda Kim, Beth Stuart, Taeko Becque, Nick Sheron, Isabelle Chemin. Local care and treatment of liver disease (LOCATE) – A cluster-randomized feasibility study to discover, assess and manage early liver disease in primary carePLOS ONE 2018; 13(12): e0208798 doi: 10.1371/journal.pone.0208798
80
Jose Hernandez Roman, Samarth Patel. Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease?Gastroenterology Clinics of North America 2020; 49(1): 95 doi: 10.1016/j.gtc.2019.10.001
81
Pang-Yen Liu, Yu-Kai Lin, Kai-Wen Chen, Kun-Zhe Tsai, Yen-Po Lin, Eiki Takimoto, Gen-Min Lin. Association of Liver Transaminase Levels and Long-Term Blood Pressure Variability in Military Young Males: The CHIEF StudyInternational Journal of Environmental Research and Public Health 2020; 17(17): 6094 doi: 10.3390/ijerph17176094
82
Andrea C. Postmus, Ines Sturmlechner, Johan W. Jonker, Jan M. van Deursen, Bart van de Sluis, Janine K. Kruit. Senescent cells in the development of cardiometabolic diseaseCurrent Opinion in Lipidology 2019; 30(3): 177 doi: 10.1097/MOL.0000000000000602
83
Sangmin You, Ai-Min Cui, Syed F. Hashmi, Xinmu Zhang, Christina Nadolny, Yuan Chen, Qiwen Chen, Xin Bush, Zachary Hurd, Winifer Ali, Gang Qin, Ruitang Deng. Dysregulation of bile acids increases the risk for preterm birth in pregnant womenNature Communications 2020; 11(1) doi: 10.1038/s41467-020-15923-4
84
Yongjia Li, Xinming Su, Nidhi Rohatgi, Yan Zhang, Jonathan R. Brestoff, Kooresh I. Shoghi, Yalin Xu, Clay F. Semenkovich, Charles A. Harris, Lindsay L. Peterson, Katherine N. Weibaecher, Steven L. Teitelbaum, Wei Zou. Hepatic lipids promote liver metastasisJCI Insight 2020; 5(17) doi: 10.1172/jci.insight.136215
85
Keyang Xu, Xu Zhao, Xiaoqing Fu, Kechen Xu, Zhaoyi Li, Liangbin Miao, Yan Li, Zhaobin Cai, Liang Qiao, Jianfeng Bao. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic studyBiomedicine & Pharmacotherapy 2019; 117: 109158 doi: 10.1016/j.biopha.2019.109158
86
N. M. Delzenne, C. Knudsen, M. Beaumont, J. Rodriguez, A. M. Neyrinck, L. B. Bindels. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axisProceedings of the Nutrition Society 2019; 78(3): 319 doi: 10.1017/S0029665118002756
87
Reza Etminani, ZaharaAbdul Manaf, Suzana Shahar, Leila Azadbakht, Peyman Adibi. Predictors of nonalcoholic fatty liver disease among middle-aged IraniansInternational Journal of Preventive Medicine 2020; 11(1): 113 doi: 10.4103/ijpvm.IJPVM_274_19
88
Olfa Khalifa, Khaoula Errafii, Nayla S. Al-Akl, Abdelilah Arredouani. Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis BiomarkersDisease Markers 2020; 2020: 1 doi: 10.1155/2020/8822859
89
Takahiro Iwasaki, Akiko Hirose, Tetsuji Azuma, Tamie Ohashi, Kazutoshi Watanabe, Akihiro Obora, Fumiko Deguchi, Takao Kojima, Atsunori Isozaki, Takaaki Tomofuji. Correlation between ultrasound-diagnosed non-alcoholic fatty liver and periodontal condition in a cross-sectional study in JapanScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-25857-z
90
Hira Hanif, Muzammil M. Khan, Mukarram J. Ali, Pir A. Shah, Jinendra Satiya, Daryl T.Y. Lau, Aysha Aslam. A New Endemic of Concomitant Nonalcoholic Fatty Liver Disease and Chronic Hepatitis BMicroorganisms 2020; 8(10): 1526 doi: 10.3390/microorganisms8101526
91
Toshihiro Sakai, Hiroyuki Ohba, Shingo Nishiyama, Takeharu Kakiuchi, Osamu Inoue, Hideo Tsukada. Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with 18F-BCPP-BFEJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0420-6
92
Konstantinos Damiris, Zaid H Tafesh, Nikolaos Pyrsopoulos. Efficacy and safety of anti-hepatic fibrosis drugsWorld Journal of Gastroenterology 2020; 26(41): 6304-6321 doi: 10.3748/wjg.v26.i41.6304
93
Kristin M Hirahatake, Richard S Bruno, Bradley W Bolling, Christopher Blesso, Lacy M Alexander, Sean H Adams. Dairy Foods and Dairy Fats: New Perspectives on Pathways Implicated in Cardiometabolic HealthAdvances in Nutrition 2019;  doi: 10.1093/advances/nmz105
94
Yunjung Choi, Chang Hun Lee, In Hee Kim, Eun Hae Park, SoJeong Park, Wan-Hee Yoo. Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control studyClinical Rheumatology 2020;  doi: 10.1007/s10067-020-05456-y
95
Fan Yang, Ping Huang, Liandong Shi, Feng Liu, Aimei Tang, Shaohui Xu. <p>Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice</p>Drug Design, Development and Therapy 2020; : 3865 doi: 10.2147/DDDT.S258857
96
T. V. Fiorentino, S. Miceli, E. Succurro, A. Sciacqua, F. Andreozzi, G. Sesti. Nonalcoholic fatty liver disease is associated with a decreased myocardial mechano‐energetic efficiencyJournal of Internal Medicine 2020;  doi: 10.1111/joim.13155
97
Qin Liu, Chun-Yan Niu. From “two hit theory” to “multiple hit theory”: Implications of evolution of pathogenesis concepts for treatment of non-alcoholic fatty liver diseaseWorld Chinese Journal of Digestology 2019; 27(19): 1171 doi: 10.11569/wcjd.v27.i19.1171
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
98
Christian L. Horn, Anvi C. Ta, Nadege T. Gunn. Current and Emerging Treatments for Non-alcoholic SteatohepatitisCurrent Hepatology Reports 2020;  doi: 10.1007/s11901-020-00540-y
99
Zobair M. Younossi, Maria Stepanova, Issah Younossi, Andrei Racila. Validation of Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis in Patients With Biopsy-Proven Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology 2019; 17(10): 2093 doi: 10.1016/j.cgh.2019.01.001
100
Sathiyamoorthy Selladurai, Abhilash Verma, Arun K. Thittai. Toward Quantitative and Operator-independent Quasi-static Ultrasound Elastography: An Ex Vivo Feasibility StudyUltrasonic Imaging 2020; 42(4-5): 179 doi: 10.1177/0161734620921532
101
Long Le, Ravina Kullar, Hussein M. Saleh, Sammy Saab. Preferred Noninvasive Testing for Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2020; 65(12): 3719 doi: 10.1007/s10620-020-06382-4
102
Ling-Yan Yu, Wei-Ying Li, Jia Lin. Juglanin improves lipid metabolism disorder, liver injury, and intestinal integrity in nonalcoholic fatty liver miceWorld Chinese Journal of Digestology 2020; 28(4): 113 doi: 10.11569/wcjd.v28.i4.113
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
103
Chiranjeevi Gadiparthi, Moshe Spatz, Simi Greenberg, Umair Iqbal, Sowjanya Kanna, Sanjaya K Satapathy, Arkady Broder, Aijaz Ahmed. NAFLD Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications and the Trends in the United StatesJournal of Clinical and Translational Hepatology 2020; 8(2): 215 doi: 10.14218/JCTH.2020.00014
104
Kun Lian, Yu‐Nan Feng, Rong Li, Hao‐Lin Liu, Peng Han, Lei Zhou, Cheng‐Xiang Li, Qin Wang. Middle‐ and high‐molecular weight adiponectin levels in relation to nonalcoholic fatty liver diseaseJournal of Clinical Laboratory Analysis 2020; 34(4) doi: 10.1002/jcla.23148
105
Seth A. Waits, Kyle H. Sheetz, Amir A. Ghaferi. Considering Bariatric Surgery in Patients With Nonalcoholic Steatohepatitis—Worth the RiskJAMA Network Open 2019; 2(2): e190053 doi: 10.1001/jamanetworkopen.2019.0053
106
Zhe Jiang, Takuya Hayashi, Kentaro Kashima, Kayo Kurotani, Bungo Shirouchi, Tetsuya Mizoue, Masao Sato. Alteration of Serum Phospholipid n‐6 Polyunsaturated Fatty Acid Compositions in Nonalcoholic Fatty Liver Disease in the Japanese Population: A Cross‐Sectional Study Lipids 2020; 55(6): 599 doi: 10.1002/lipd.12251
107
Bertha Marin-Alejandre, Itziar Abete, Irene Cantero, Jose Riezu-Boj, Fermín Milagro, J. Monreal, Mariana Elorz, José Herrero, Alberto Benito-Boillos, Jorge Quiroga, Ana Martinez-Echeverria, Juan Uriz-Otano, María Huarte-Muniesa, Josep Tur, J. Martínez, M. Zulet. Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy ControlsNutrients 2019; 11(2): 322 doi: 10.3390/nu11020322
108
Fabian Seebacher, Anja Zeigerer, Nora Kory, Natalie Krahmer. Hepatic lipid droplet homeostasis and fatty liver diseaseSeminars in Cell & Developmental Biology 2020;  doi: 10.1016/j.semcdb.2020.04.011
109
Antonio De Vincentis, Zahra Rahmani, Moises Muley, Umberto Vespasiani-Gentilucci, Sergio Ruggiero, Parvin Zamani, Tannaz Jamialahmadi, Amirhossein Sahebkar. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatmentDrug Discovery Today 2020; 25(7): 1277 doi: 10.1016/j.drudis.2020.05.009
110
Yinhua Ni, Yufeng Zhao, Lingyan Ma, Zhe Wang, Liyang Ni, Luting Hu, Zhengwei Fu. Pharmacological activation of REV-ERBα improves nonalcoholic steatohepatitis by regulating intestinal permeabilityMetabolism 2021; 114: 154409 doi: 10.1016/j.metabol.2020.154409
111
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver DiseaseAlternative and Complementary Therapies 2020;  doi: 10.1089/act.2020.29303.klu
112
Hideo Ohuchi. What are the mechanisms for FALD and how can we prevent the progression?International Journal of Cardiology 2018; 273: 121 doi: 10.1016/j.ijcard.2018.09.071
113
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver TransplantGastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
114
Rishi Rikhi, Tavankit Singh, Jamak Modaresi Esfeh. Work up of fatty liver by primary care physicians, reviewAnnals of Medicine and Surgery 2020; 50: 41 doi: 10.1016/j.amsu.2020.01.001
115
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severityLiver International 2019; 39(9): 1742 doi: 10.1111/liv.14167
116
Valentina A. Zavala, Paige M. Bracci, John M. Carethers, Luis Carvajal-Carmona, Nicole B. Coggins, Marcia R. Cruz-Correa, Melissa Davis, Adam J. de Smith, Julie Dutil, Jane C. Figueiredo, Rena Fox, Kristi D. Graves, Scarlett Lin Gomez, Andrea Llera, Susan L. Neuhausen, Lisa Newman, Tung Nguyen, Julie R. Palmer, Nynikka R. Palmer, Eliseo J. Pérez-Stable, Sorbarikor Piawah, Erik J. Rodriquez, María Carolina Sanabria-Salas, Stephanie L. Schmit, Silvia J. Serrano-Gomez, Mariana C. Stern, Jeffrey Weitzel, Jun J. Yang, Jovanny Zabaleta, Elad Ziv, Laura Fejerman. Cancer health disparities in racial/ethnic minorities in the United StatesBritish Journal of Cancer 2020;  doi: 10.1038/s41416-020-01038-6
117
Isabel Molwitz, Miriam Leiderer, Cansu Özden, Jin Yamamura. Dual-Energy Computed Tomography for Fat Quantification in the Liver and Bone Marrow: A Literature ReviewRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 2020; 192(12): 1137 doi: 10.1055/a-1212-6017
118
Steffen Landerer, Sandra Kalthoff, Stefan Paulusch, Christian P. Strassburg. A Gilbert syndrome-associated haplotype protects against fatty liver disease in humanized transgenic miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65481-4
119
Timothy M.E. Davis, Kirsten E. Peters, S. A. Paul Chubb, Leon A. Adams, Gary P. Jeffrey, Wendy A. Davis. Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyJournal of Clinical Medicine 2020; 9(11): 3409 doi: 10.3390/jcm9113409
120
Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, Simonetta Lugari, Giovanni Targher. Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?Digestive and Liver Disease 2019; 51(4): 462 doi: 10.1016/j.dld.2018.12.014
121
Cheng Fang, Paul S. Sidhu. Ultrasound-based liver elastography: current results and future perspectivesAbdominal Radiology 2020; 45(11): 3463 doi: 10.1007/s00261-020-02717-x
122
Chang-hua Zhang, Bu-gao Zhou, Jun-qing Sheng, Yang Chen, Ying-qian Cao, Chen Chen. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategiesPharmacological Research 2020; 159: 104984 doi: 10.1016/j.phrs.2020.104984
123
Egor V. Kalinin, Yaroslava M. Chalenko, Elena V. Sysolyatina, Konstantin Y. Midiber, Alexey M. Gusarov, Olga I. Kechko, Alexandra A. Kulikova, Ludmila M. Mikhaleva, Andrey Ya. Mukhachev, Yaroslav M. Stanishevskyi, Vladimir A. Mitkevich, Konstantin A. Sobyanin, Svetlana A. Ermolaeva. Bacterial hepatocyte growth factor receptor agonist stimulates hepatocyte proliferation and accelerates liver regeneration in a partial hepatectomy rat modelDrug Development Research 2020;  doi: 10.1002/ddr.21737
124
Esther Rey, Elvira del Pozo-Maroto, Patricia Marañón, Brittany Beeler, Yaiza García-García, Pedro Landete, Stephania C. Isaza, Ramón Farré, Carmelo García-Monzón, Isaac Almendros, Águeda González-Rodríguez. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep ApneaFrontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00450
125
Minjie Lin, Jungke Long, Wenbo Li, Chenxuan Yang, Patricia Loughran, Robert O’Doherty, Timothy R. Billiar, Meihong Deng, Melanie J. Scott. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feedingMolecular Medicine 2020; 26(1) doi: 10.1186/s10020-020-00227-6
126
Teresa Vanessa Fiorentino, Elena Succurro, Angela Sciacqua, Francesco Andreozzi, Francesco Perticone, Giorgio Sesti. Non‐alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose toleranceDiabetes/Metabolism Research and Reviews 2020; 36(8) doi: 10.1002/dmrr.3333
127
Kavita Jadhav, Taylor S. Cohen. Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASHFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.592157
128
Nina L. Gluchowski, Katlyn R. Gabriel, Chandramohan Chitraju, Roderick T. Bronson, Niklas Mejhert, Sebastian Boland, Kun Wang, Zon Weng Lai, Robert V. Farese, Tobias C. Walther. Hepatocyte Deletion of Triglyceride‐Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in MiceHepatology 2019; 70(6): 1972 doi: 10.1002/hep.30765
129
Nikta Afzali, Seyed Shayan Ebadi, Hasan Afzali, Mohammad Reza Sharif, Mahdi Vazirian, Seyed Alireza Ebadi, Vahid Shahkarami, Habibollah Rahimi. Effect of Beta vulgaris Extract on Liver Enzymes in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Clinical TrialHepatitis Monthly 2020; 20(7) doi: 10.5812/hepatmon.102125
130
Maria Wallert, Lisa Börmel, Stefan Lorkowski. Inflammatory Diseases and Vitamin E—What Do We Know and Where Do We Go?Molecular Nutrition & Food Research 2020; : 2000097 doi: 10.1002/mnfr.202000097
131
Meng Zhang, Li Li, Jing Chen, Bei Li, Yutao Zhan, Chuan Zhang. Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver diseaseMedicine 2019; 98(18): e15362 doi: 10.1097/MD.0000000000015362
132
Cindy X. Cai, Stella Carlos, Pejman Solaimani, Bansari J. Trivedi, Chuong Tran, Shobha Castelino-Prabhu. Dietary Interventions in Liver Disease2019; : 357 doi: 10.1016/B978-0-12-814466-4.00029-X
133
Leslimar Rios-Colon, Elena Arthur, Suryakant Niture, Qi Qi, John T. Moore, Deepak Kumar. The Role of Exosomes in the Crosstalk between Adipocytes and Liver Cancer CellsCells 2020; 9(9): 1988 doi: 10.3390/cells9091988
134
Aparamita Pandey, Prachi Dabhade, Anand Kumarasamy. Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose TissueDose-Response 2019; 17(2): 155932581984338 doi: 10.1177/1559325819843380
135
Jing Guo, Ingolf Sack, Stephan Rodrigo Marticorena Garcia. Liver Elastography2020; : 69 doi: 10.1007/978-3-030-40542-7_6
136
A. Tvarijonaviciute, R. Barić-Rafaj, A. Horvatic, A. Muñoz-Prieto, N. Guillemin, E. Lamy, A. Tumpa, J.J. Ceron, S. Martinez-Subiela, V. Mrljak. Identification of changes in serum analytes and possible metabolic pathways associated with canine obesity-related metabolic dysfunctionThe Veterinary Journal 2019; 244: 51 doi: 10.1016/j.tvjl.2018.12.006
137
Yvonne Huber, Jörn M Schattenberg. Prävention gastroenterologischer Tumorerkrankungen2020; : 173 doi: 10.1007/978-3-662-58879-6_10
138
Evan E. Lebovitz, Anh Vinh T. Nguyen, Tetsuro Sakai. Economic considerations in abdominal transplantationBest Practice & Research Clinical Anaesthesiology 2020; 34(1): 15 doi: 10.1016/j.bpa.2020.01.002
139
Derek J. Erstad, Allen A. Razavi, Shen Li, Kenneth K. Tanabe, Bryan C. Fuchs. Hepatocellular CarcinomaMolecular and Translational Medicine 2019; : 255 doi: 10.1007/978-3-030-21540-8_13
140
Lyssia Castellanos-Tapia, María Elizabeth Tejero-Barrera, Soraya Salas-Silva, Arturo Simoni-Nieves, Alejandro Escobedo-Calvario, Luis E. Gomez-Quiroz. Mediterranean-like mix of fatty acids induces cellular protection on lipid-overloaded hepatocytes from western diet fed miceAnnals of Hepatology 2020; 19(5): 489 doi: 10.1016/j.aohep.2020.06.005
141
Vinod K. Rustgi, You Li, Tina John, Carolyn Catalano, Mohamed I. Elsaid. Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real‐World Claims AnalysisHepatology Communications 2020; 4(10): 1404 doi: 10.1002/hep4.1573
142
Acharya Balkrishna, Vivek Gohel, Rani Singh, Monali Joshi, Yash Varshney, Jyotish Srivastava, Kunal Bhattacharya, Anurag Varshney. Tri-Herbal Medicine Divya Sarva-Kalp-Kwath (Livogrit) Regulates Fatty Acid-Induced Steatosis in Human HepG2 Cells through Inhibition of Intracellular Triglycerides and Extracellular Glycerol LevelsMolecules 2020; 25(20): 4849 doi: 10.3390/molecules25204849
143
Fatemeh Haidari, Abdollah Hojhabrimanesh, Bizhan Helli, Seyed-Saeed Seyedian, Kambiz Ahmadi-Angali, Behnaz Abiri. A hypocaloric high-protein diet supplemented with β-cryptoxanthin improves non-alcoholic fatty liver disease: a randomized controlled trialBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01502-w
144
Nirmalya Sinha, Saptarshi Mukhopadhyay, Manabendra Sau. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesityIndian Journal of Gastroenterology 2020; 39(1): 75 doi: 10.1007/s12664-020-01020-3
145
Nigel S. Cook, Julie Cave, Anke-Peggy Holtorf. Patient Preference Studies During Early Drug Development: Aligning Stakeholders to Ensure Development Plans Meet Patient NeedsFrontiers in Medicine 2019; 6 doi: 10.3389/fmed.2019.00082
146
Karn Wijarnpreecha, Melissa Scribani, Pascale Raymond, Denise M Harnois, Andrew P Keaveny, Aijaz Ahmed, Donghee Kim. PNPLA3 gene polymorphism and overall and cardiovascular mortality in the United States Journal of Gastroenterology and Hepatology 2020; 35(10): 1789 doi: 10.1111/jgh.15045
147
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetesDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
148
Yogesh Yadav, Wing-Kin Syn, Rita Basu. Evolving Management Strategies for Nonalcoholic Fatty Liver Disease–Targeting Primary Care PhysiciansDiabetes Technology & Therapeutics 2019; 21(11): 611 doi: 10.1089/dia.2019.0158
149
Seyed Mostafa Parizadeh, Seyed Alireza Parizadeh, Mohadese Alizade-Noghani, Reza Jafarzadeh-Esfehani, Maryam Ghandehari, Ali Mottaghi-Moghaddam, Fatemeh Goldani, Majid Khazaei, Majid Ghayour-Mobarhan, Gordon A. Ferns, Seyed Mahdi Hassanian, Amir Avan. Association between non-alcoholic fatty liver disease and colorectal cancerExpert Review of Gastroenterology & Hepatology 2019; 13(7): 633 doi: 10.1080/17474124.2019.1617696